MyFinsight
Home
About
Contact
asrt: the income statement
Download
Download image
Product Other
$1,526K
SPRIX
$1,686K
Sympazan
$2,833K
INDOCIN
$4,847K
Rolvedon
$38,567K
Product
$49,459K
Total revenues
$49,459K
(69.36%↑ Y/Y)
Income (loss) from
operations
$11,478K
(476.57%↑ Y/Y)
Total costs and
expenses
$37,981K
(17.76%↑ Y/Y)
Change in fair value of
contingent consideration
-$276K
(-192.00%↓ Y/Y)
Income tax benefit
(expense)
-$47K
(-206.82%↓ Y/Y)
Net income (loss)
before income taxes
$11,398K
(496.18%↑ Y/Y)
Total other (expense)
income
-$80K
(-146.78%↓ Y/Y)
Other gain
$26K
Interest income
$664K
(-25.14%↓ Y/Y)
Impairment of intangible
assets
$1,700K
Amortization of intangible
assets
$5,594K
(-16.14%↓ Y/Y)
Selling, general and
administrative expenses
$16,930K
(1.22%↑ Y/Y)
Research and development
expenses
$379K
(-62.29%↓ Y/Y)
Cost of sales
$13,654K
(80.85%↑ Y/Y)
Net income (loss)
and comprehensive...
$11,445K
(491.82%↑ Y/Y)
Interest expense
$770K
(1.18%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Assertio Holdings, Inc. (ASRT)
Assertio Holdings, Inc. (ASRT)